RESOLVED, that the Pennsylvania Medical Society amend Policy 95.993, H-2009, Education on Overdose Prevention/Naloxone Prescribing by addition and deletion to read as follows: 

Policy:
PAMED (1) promotes overdose prevention education to patients and their families; (2) promotes physician education on naloxone prescribing, including risk assessment of patients, resources available to learn more about available programs, and how best to proceed when the decision is made to prescribe; (3)advocate for a state-wide mandatory integration of naloxone education and administration training into preclinical training to provide medical students with the tools and knowledge to comfortably intervene and combat the opioid crisis in Pennsylvania; (3) (4) will expand the Pain Management Work Group to include expertise on overdose prevention and naloxone prescribing; (4) (5) advocates to expand the mission of the  Pennsylvania Pain Coalition to include physician and public overdose education goals and continue to work with the coalition and other nonprofit organizations to develop patient education materials about naloxone use as part of a public education program. This program should focus on appropriate pain management therapies and their adverse side effects, as well as the importance of having realistic expectations for pain control; and (5) (6) will continue to monitor research on naloxone prescribing, including the Lazarus Project.